The Tumor Microenvironment

Slides:



Advertisements
Similar presentations
Upfront Combination Therapy vs Step-Up Approach for PAH:
Advertisements

The Nurse’s Role in Inflammatory Bowel Disease
Expert Perspectives on New Treatment Options for Parkinson Disease Psychosis.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Immunotherapies: Key Considerations in the Identification and Management of irAEs.
CDK 4 and 6 Inhibitors in HR-Positive Breast Cancer: Implementing Paradigms in Clinical Practice.
A New Path Forward: Immune Checkpoint Inhibitors in Bladder Cancer
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.
T-Cell Exhaustion: Can We Overcome It in Cancer?
New Therapies for Hyperkalemia Across the Continuum of Care
Introduction. Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Endocrine System.
Chronic Rhinosinusitis
Learning Objectives. A Multidisciplinary Approach in Advanced NSCLC in the Era of Immuno-Oncology.
Hemophilia Updates: Incorporating New Concepts Into Practice
The Nurse View: Overcoming Challenges Associated With Cancer Immunotherapy.
Complicated Cases in Ulcerative Colitis
Program Goals Introduction Case 1: A 44-Year-Old Woman.
Chronic Idiopathic Urticaria
Management of Glioblastoma
Tailoring Hemophilia Prophylaxis Therapy
Optimizing Management of Advanced Bladder Cancer
Checkpoint Inhibition
The Nurse View: Top Ten Things to Know About Immune-Mediated Adverse Events.
Overview. Maximizing the Safety of CAR T-Cell Therapy: Prevention, Early Recognition, and Management.
Checkpoint Inhibition
Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Genitourinary Tract.
Patient Case: KC. Optimizing Treatment of Mild to Moderate Ulcerative Colitis: A Case-Based Perspective.
Targeting Osteoporosis Therapies to Patients at Highest Risk for Fracture.
Gene Therapy: Past, Present, and Future
Introduction. Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Skin.
Managing Adverse Events With New Oral Therapies in CLL
Ask the Experts.
Optimizing Outcomes and Managing Adverse Events in CLL
Immunotherapy for cSCC
Updates in Neurogenic Orthostatic Hypotension
Hiding in Plain Sight: How Cancer Evades the Immune System
Translating the Latest and Greatest Advances in PAH Into Clinical Practice.
When Is Biologic Therapy Appropriate for HS?
Managing Polycythemia Vera in the Community Setting
Nurse View: Practice Pearls in Advanced Pancreatic Adenocarcinoma
Expert Perspectives on the Clinical Use of Immune Reconstitution vs Escalation Therapy for MS.
Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.
When to Start and What to Use
Understanding the Updated Guidelines for ALK Testing in NSCLC
Changing the Paradigm of Treatment in Patients With Hodgkin Lymphoma
Patient Questions and Expert Answers in Psoriasis:
Severe Asthma and Comorbidities
Biomarker Testing: Harnessing All Sides of the Tumor Microenvironment
Management of Advanced Pancreatic Adenocarcinoma
Are We Making Progress in the Management of Huntington Disease?
Possible Causes of imAEs
Challenges and Opportunities
From Adjuvant to Metastatic in Melanoma
Immune Checkpoint Inhibitors in EGFR-Mutated NSCLC
The Nurse View: Spotlight on Immune Checkpoint Inhibitors in Advanced Lung Cancer.
Program Goal. Program Goal Disclaimer Overview.
Activity Goals. Clinical Considerations in the Use of Immune Checkpoint Inhibitors in Advanced NSCLC.
Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition
This program will include a discussion of off-label treatment or use of investigational agents not approved by the FDA for use in the US, and data that.
The Nurse View: Spotlight on EGFR-Mutated NSCLC
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Patient and Clinician Perspectives on Preventive Therapy for Migraine
Tardive Dyskinesia 101.
Merging the Art and Science of Managing nOH in Clinical Practice
Mitigating Side Effects and Optimizing Compliance With Oral Therapies in CLL.
Immune Checkpoint Inhibitors in Lung Cancer
Exploring the Use of Adeno-Associated Virus for Gene Therapy
The Nurse View.
The Nurse View: Practice Pearls in the Use of Immune Checkpoint Inhibitors in Advanced NSCLC.
Overview of irAEs. Management of Immune-Related Adverse Events for Patients Receiving Checkpoint Inhibitor Therapy.
Presentation transcript:

Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the GI Tract

The Tumor Microenvironment

Overview of imAEs

imAEs Affecting the GI Tract

Pretreatment Evaluation and Screening

Case 1

Colitis

Workup

Grading Symptoms

Management of Colitis

Response to Steroids

Tapering Off Steroids

Restarting Therapy

Oncologist and Gastroenterologist Working Together

Case 2

Upper GI Symptoms

Gastritis

Case 2 Conclusion

Pancreatitis

Small Bowel Enteritis

Concluding Remarks

Abbreviations

Abbreviations (cont)

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.